GlassScriptPhysician profile
Trey Durdin
NPI 1003295320
$2,862.96
in general payments reported to CMS, 2019-2025
14 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $244 · 2021: $92.59 · 2022: $61.09 · 2023: $1,204 · 2024: $417 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442 · Travel and Lodging: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.32 |
| Travel and Lodging | $472.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,239.52 | 2023-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $357.80 | 2019-2024 | Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $327.70 | 2024-2025 | Aquabeam System |
| Cook Medical LLC | $302.23 | 2019-2024 | Litho 150 |
| Endo Pharmaceuticals INC. | $119.38 | 2019 | |
| Pfizer INC. | $112.38 | 2020 | |
| Urogen Pharma, INC. | $98.85 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $92.59 | 2021 | |
| Astellas Pharma US INC | $64.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $53.18 | 2025 | Lynparza |
| Teleflex LLC | $29.38 | 2025 | Barrigel |
| Coloplast Corp | $29.25 | 2023 | Speedicath |
| Photocure INC | $22.02 | 2023 | Cysview |
| 180 Medical, INC. | $13.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trey Durdin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.